Lv4
440 积分 2023-04-18 加入
Universal pipeline for high-resolution GPCR structure determination
8小时前
已完结
Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?
5天前
已完结
Discovery and Characterization of RP04340 : A Highly Potent and Orally Active Pan-KRAS PROTAC Degrader
6天前
已完结
First‐in‐human study with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5aR1) antagonist, supported by pharmacokinetic predictions from animals to patients
11天前
已完结
Discovery and Characterization of a New Class of C5aR1 Antagonists Showing In Vivo Activity
11天前
已完结
Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain
12天前
已完结
Oral Small-Molecule GLP-1 Receptor Agonists: Lessons from Clinical Candidates and a Blueprint for Next-Generation Design
12天前
已完结
Discovery of new indole-based acylsulfonamide Nav1.7 inhibitors
13天前
已完结
Effect of NaV1.7 blockers on post-ganglionic sympathetic nerve function
14天前
已关闭
Discovery and Characterization of RP04340 : A Highly Potent and Orally Active Pan-KRAS PROTAC Degrader
17天前
已完结
皖公网安备34019202002308
